MDXG (STOCKS)
MiMedx Group, Inc
$3.965800
+0.095800 (+2.48%)
Prev close: $3.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Joseph H. Capper
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $581.64M
- Employees
- 837
- P/E (TTM)
- 11.93
- P/B (TTM)
- 2.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.10 | $0.09 | +0.0143 | +16.69% |
|
Sep 2025 (Q3)
|
$0.15 | $0.07 | +0.0786 | +110.08% |
|
Jun 2025 (Q2)
|
$0.10 | $0.06 | +0.0449 | +81.49% |
|
Mar 2025 (Q1)
|
$0.06 | $0.06 | +0.0039 | +6.95% |
Financial Statements
| Revenues | $418.63M |
| Benefits Costs and Expenses | $352.37M |
| Cost Of Revenue | $73.01M |
| Costs And Expenses | $352.37M |
| Gross Profit | $345.62M |
| Operating Expenses | $281.73M |
| Selling, General, and Administrative Expenses | $266.19M |
| Research and Development | $15.10M |
| Other Operating Expenses | $439.00K |
| Operating Income/Loss | $63.89M |
| Income/Loss From Continuing Operations After Tax | $48.58M |
| Income/Loss From Continuing Operations Before Tax | $66.26M |
| Income/Loss From Discontinued Operations Net Of Tax | $0.00 |
| Income Tax Expense/Benefit | $17.68M |
| Income Tax Expense/Benefit, Current | $8.97M |
| Income Tax Expense/Benefit, Deferred | $8.71M |
| Net Income/Loss | $48.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $48.58M |
| Net Income/Loss Available To Common Stockholders, Basic | $48.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.33 |
| Diluted Earnings Per Share | $0.32 |
| Basic Average Shares | 147,793,069 |
| Diluted Average Shares | 149,724,507 |
| Assets | $342.65M |
| Current Assets | $277.47M |
| Inventory | $25.34M |
| Other Current Assets | $252.13M |
| Noncurrent Assets | $65.18M |
| Intangible Assets | $14.16M |
| Other Non-current Assets | $51.02M |
| Liabilities | $86.11M |
| Current Liabilities | $64.27M |
| Accounts Payable | $14.53M |
| Wages | $31.07M |
| Other Current Liabilities | $18.67M |
| Noncurrent Liabilities | $21.84M |
| Long-term Debt | $18.00M |
| Other Non-current Liabilities | $3.84M |
| Equity | $256.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $256.55M |
| Liabilities And Equity | $342.65M |
| Net Cash Flow From Operating Activities | $74.00M |
| Net Cash Flow From Operating Activities, Continuing | $74.00M |
| Net Cash Flow From Operating Activities, Discontinued | $0.00 |
| Net Cash Flow From Investing Activities | -$6.89M |
| Net Cash Flow From Investing Activities, Continuing | -$6.89M |
| Net Cash Flow From Financing Activities | -$5.41M |
| Net Cash Flow From Financing Activities, Continuing | -$5.41M |
| Net Cash Flow | $61.71M |
| Net Cash Flow, Continuing | $61.71M |
| Net Cash Flow, Discontinued | $0.00 |
| Comprehensive Income/Loss | $48.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $48.58M |
| Other Comprehensive Income/Loss | $0.00 |